CSGA Corporate Biography's

Name: Dr. Francis Bellido

Position:
Director, Post-Quantum Cryptography

CSGA Business Profile
Ø Over 35 years of international experience in Cybersecurity, Healthcare and Financial industries.
Ø Appointed CEO of Quantum eMotion Inc (QNC.V) in Jan 2020
Ø CEO of SoundBite Medical from 2018 to 2020 after he served as CFO from 2015 to 2018
Ø From 2007 to 2014, he served in several top executive positions in large, medium-sized and start-up companies.
Ø From 1999 to 2006, he managed a $300M life science investment Fund (SGF-Santé) and produced several major winners: Cryocath, IDI-GeneOhm, Draxis, Medicago, Atrium, Axcan Pharma
Ø Occupied several executive positions with Eli Lilly in the United States and Europe including Strategic Asset Director, Global Business Unit Manager and Head of Regulatory Affairs.
Ø He was also the director of the chair of Management in Bioindustry at the University of Quebec in Montreal where he has held the position of Invited Professor at the School of Management for 15 years.
Ø Dr. Bellido has served as Board member and Director in more than 20 private and public companies, including at the present time Diagnos (ADK.V), Magneceuticals (USA), RegenLab (CH).
Ø Former member of the board of DSM Biologics Company Inc., one of the world leading biopharmaceutical CMOs.
Ø Dr. Bellido has an MBA, a MSc. in pharmaceutical sciences and a Ph.D. in sciences from the University of Geneva, Switzerland, and he has published over 40 original manuscripts and communications in peer reviewed scientific journals.